Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201109095 Principal Investigator: Uy, Geoffrey
Title: A Phase 2, Multicenter, Randomized, Open Label, Parallel-Group Study of a Lenalidomide (Revlimid®) Regimen or a Sequential Azacitidine (Vidaza®) plus Lenalidomide (Revlimid®) Regimen versus Conventional Care Regimens for Therapy of Older Subjects with Newly Diagnosed Acute Myeloid Leukemia
Phase: II Disease Site: Myeloid and Monocytic Leukemia
Participating Site(s):
 
Main Campus
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to see if the drug lenalidomide alone or in combination with the drug azacitidine is safe and effective for use in people 65 years and older with AML. This study is being conducted to determine if these drugs will help patients with AML more than currently available treatments.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)